NCT01051934 2017-07-02A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaNational Institutes of Health Clinical Center (CC)Phase 1 Completed2 enrolled